Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Newron Pharmaceuticals SpA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 44.26% vs -1.61% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 10.23% vs -9.32% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.80",
          "val2": "6.10",
          "chgp": "44.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.10",
          "val2": "-13.10",
          "chgp": "15.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.70",
          "val2": "4.40",
          "chgp": "6.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-15.80",
          "val2": "-17.60",
          "chgp": "10.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,284.00%",
          "val2": "-2,182.80%",
          "chgp": "89.88%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

8.80

6.10

44.26%

Operating Profit (PBDIT) excl Other Income

-11.10

-13.10

15.27%

Interest

4.70

4.40

6.82%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-15.80

-17.60

10.23%

Operating Profit Margin (Excl OI)

-1,284.00%

-2,182.80%

89.88%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 44.26% vs -1.61% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 10.23% vs -9.32% in Dec 2022

All Annual Results